6533b7dcfe1ef96bd1271683

RESEARCH PRODUCT

The Impact of Depression Symptoms in Patients with Parkinson’s Disease: A Novel Case-Control Investigation

César Calvo-loboRicardo Becerro-de-bengoa-vallejoPatricia Palomo-lópezMarta Elena Losa-iglesiasAna María Jiménez-cebriánEmmanuel Navarro-floresCarlos Romero-moralesDaniel López-lópez

subject

Inventario de Depresión de Beckmedicine.medical_specialtyParkinson's diseaseHealth Toxicology and MutagenesisBeck Depression InventoryNeurocienciaslcsh:MedicineDiseasebehavioral disciplines and activitiesArticle03 medical and health sciences0302 clinical medicineInternal medicineDepresiónmedicineHumansIn patient030212 general & internal medicineDepression (differential diagnoses)Social functioningAgedbusiness.industryDepressionSignificant differencelcsh:RPublic Health Environmental and Occupational HealthHealthy subjectsBeck Depression InventoryNeurodegenerative DiseasesParkinson DiseaseMiddle Agedmedicine.diseasehumanitiesPsicologíaParkinson diseaseCaregiversbeck depression inventoryEnfermedad de ParkinsonCase-Control StudiesdepressionSistema nerviós Malaltiesbusiness030217 neurology & neurosurgery

description

Parkinson’s disease is a common neurodegenerative disease and it is known to cause motor disturbances associated with musculoskeletal problems of the locomotor apparatus, and non-motor symptoms, that are believed to have a harmful effect on health, social functioning and mobility. The aim of this study was to evaluate depression in patients with Parkinson’s Disease (PD) compared to subjects who do not have it. The sample consisted of 124 participants (mean age 69.18 ± 9.12). Patients with PD were recruited from a center of excellence for Parkinson’s disease (cases n = 62) and healthy subjects without PD from their relatives and caregivers (control n = 62). The Spanish version of Beck’s Depression Inventory (BDI) scores and categories were collected. A clear statistically significant difference (p &lt

https://hdl.handle.net/2183/30185